Wellington Management Group LLP Has $47.53 Million Position in ProAssurance Co. (NYSE:PRA)

Wellington Management Group LLP cut its holdings in ProAssurance Co. (NYSE:PRA) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,987,196 shares of the insurance provider’s stock after selling 176,889 shares during the quarter. Wellington Management Group LLP owned about 0.06% of ProAssurance worth $47,526,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in PRA. State Street Corp lifted its stake in shares of ProAssurance by 1.8% in the 3rd quarter. State Street Corp now owns 1,968,754 shares of the insurance provider’s stock valued at $29,610,000 after purchasing an additional 34,247 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of ProAssurance by 0.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,316,249 shares of the insurance provider’s stock worth $20,678,000 after buying an additional 4,814 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of ProAssurance by 92.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 690,871 shares of the insurance provider’s stock worth $10,992,000 after acquiring an additional 331,224 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of ProAssurance by 17.2% during the 4th quarter. American Century Companies Inc. now owns 391,609 shares of the insurance provider’s stock valued at $6,230,000 after acquiring an additional 57,556 shares during the last quarter. Finally, Zacks Investment Management bought a new position in shares of ProAssurance in the 3rd quarter valued at approximately $5,140,000. 85.58% of the stock is owned by institutional investors.

ProAssurance Stock Down 0.4 %

Shares of PRA stock opened at $23.26 on Friday. ProAssurance Co. has a 12 month low of $10.76 and a 12 month high of $23.43. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. The firm has a market cap of $1.19 billion, a PE ratio of 28.02 and a beta of -0.09. The stock has a 50 day moving average of $17.07 and a 200-day moving average of $16.12.

ProAssurance (NYSE:PRA) last issued its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million during the quarter, compared to the consensus estimate of $274.56 million. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. On average, equities analysts predict that ProAssurance Co. will post 0.8 EPS for the current year.

Wall Street Analyst Weigh In

PRA has been the topic of several analyst reports. Citizens Jmp downgraded ProAssurance from an “outperform” rating to a “market perform” rating in a report on Thursday. StockNews.com initiated coverage on shares of ProAssurance in a report on Tuesday, April 1st. They issued a “hold” rating on the stock. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, ProAssurance currently has a consensus rating of “Hold” and an average price target of $18.67.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.